Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.

What fueled the previous growth in the market?

The market for spinal stenosis treatment has been expanding consistently in recent times. Expected to escalate from $10.20 billion in 2024 to $10.64 billion in 2025 with a compound annual growth rate (CAGR) of 4.4%, this growth is facilitated by a rise in degenerative spinal issues, an increasingly ageing global population, heightened awareness of disorders related to the spine, growing healthcare expenditure and insurance provisions, and an increasing appetite for less invasive surgical methods.

What will be the market size in the future?

The market for spinal stenosis treatment is poised for consistent expansion in the upcoming years, with estimations predicting its growth to $12.45 billion in 2029, reflecting a compound annual growth rate (CAGR) of 4.0%. The projected growth in this period can be accredited to the increasing instances of spinal stenosis and its associated degenerative disorders, an upsurge in the usage of minimally invasive surgeries, heightened preference for non-surgical treatment alternatives, a rise in consciousness regarding spinal health and its available treatments, and an enhanced concentration on pain control and regenerative therapies. The main trends for this period entail advancements in the technology of implants and devices, the introduction of telehealth and digital health solutions, a conducive regulatory framework and beneficial reimbursement policies, the use of artificial intelligence and robotics in surgical prescriptions and treatment, emphasis on individualized treatment strategies, and solutions tailored for specific patients.

Get your market report here!

https://www.thebusinessresearchcompany.com/report/spinal-stenosis-treatment-global-market-report

What are the leading drivers of growth in the market?

The expected surge in spinal disorders is predicted to stimulate the advancement of the spinal stenosis treatment market. Spinal disorders encompass conditions that impact the spine’s bones, discs, nerves, or soft tissues, which can result in pain, movement difficulties, or neurological symptoms. The escalation in spinal disorders can be attributed to aging, inactive lifestyles, obesity, poor positioning, occupational threats, and enhanced diagnostics. Spinal stenosis treatment comes into play in spinal disorders to provide relief from nerve contraction, diminish pain, and enhance movement in situations like degenerative disc disease and ruptured discs. For example, Spinal Cord, Inc., a medical device organization based in the US, reported in May 2023 that around 18,000 new spinal cord injury (SCI) cases are reported yearly in the United States, with an approximate figure of 302,000 individuals currently grappling with SCI around the country. Therefore, the surge in spinal disorders highlights the growth of the spinal stenosis treatment market.

What key areas define the segmentation of the global market?

The spinal stenosis treatment market covered in this report is segmented –

1) By Type: Cervical Stenosis, Lumbar Stenosis

2) By Treatment: Medication, Physical Therapy, Surgery, Other Treatments

3) By End Users: Hospitals, Homecare, Specialty Clinics, Other End-Users

Subsegments:

1) By Cervical Stenosis: Physical Therapy, Medications, Spinal Injections, Decompression Surgery, Spinal Fusion

2) By Lumbar Stenosis: Pain Management, Epidural Steroid Injections, Minimally Invasive Procedures, Laminectomy, Artificial Disc Replacement

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21289&type=smp

Who are the dominant players expanding their reach in the market?

Major companies operating in the spinal stenosis treatment market are Johnson & Johnson, Medtronic plc, Zimmer Biomet Holdings Inc., Sumitomo Dainippon Pharma Co. Ltd, Ono Pharmaceutical Co. Ltd, Stryker Corporation, Globus Medical Inc., Orthofix Holdings Inc., Aesculap Implant Systems LLC, Alphatec Spine Inc, RTI Surgical Holdings Inc, B. Braun Melsungen AG, Spinal Elements Inc., Xtant Medical Holdings Inc., Precision Spine Inc., Spineart SA, Yungjin Pharm Co. Ltd, Zavation Medical Products LLC, Aurora Spine Corporation, Empirical Spine Inc.

How are evolving market trends shaping Strategies?

Key companies within the spinal stenosis treatment market are emphasizing the development of innovative solutions such as minimally invasive surgery (MIS) implants. These implants are designed to improve the availability of minimally invasive surgical procedures, better patient outcomes, and decrease recovery periods. The advantage of MIS implants is that they can be implanted through minimally invasive surgical techniques, which decrease trauma, recovery duration, and complications compared to conventional open surgery. For example, Aurora Spine, a US medical device firm, got clearance from the U.S. Food and Drug Administration (FDA) in July 2022 to broaden the use of its ZIP MIS implants for lumbar spinal stenosis, a condition characterized by the narrowing of the spinal canal which can result in back and leg pain. Previously, these implants were only approved for conditions such as degenerative disc disease, spondylolisthesis, trauma, and tumors. This new approval allows doctors to treat a wider range of patients. This improvement broadens the treatment alternatives available for those afflicted by spinal stenosis.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21289

Which regions are emerging as leaders in the market?

North America was the largest region in the spinal stenosis treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the spinal stenosis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Biosimilar Growth Hormones Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/biosimilar-growth-hormone-global-market-report

Human Growth Hormone Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/human-growth-hormone-global-market-report

Biosimilar Hormones Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/biosimilar-hormone-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: